Perbedaan Kadar Psa dan TGF-B1 Terhadap Pemberian Kombinasi Inhibator 5A-Reduktase (Dutasteride) dan Anti Estrogen (Tamoxifen) Pada Pasien BPH LUTS

• Main Authors: Rachmat Budi Prasetyo, Soetojo, Doddy M. Soebadi, Hendromartono, Endang Retnowati, Widayat S., Widodo Jatim Pudjirahardjo
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Ikatan Ahli Urologi Indonesia 2008
• Subjects: R Medicine (General); RD520-599.5 Surgery by region, system, or organ
• Online Access: http://repository.unair.ac.id/89459/1/PERBEDAAN%20KADAR%20PSA%20DAN%20TGF-%CE%B21%20TERHADAP%20PEMBERIAN.pdf; http://repository.unair.ac.id/89459/4/Perbedaan%20Kadar%20PSA%20dan%20TGF-Beta1.pdf; http://repository.unair.ac.id/89459/6/PERBEDAAN%20KADAR%20PSA%20DAN%20TGF-%CE%B21%20TERHADAP%20PEMBERIAN%20KOMBINASI%20INHIBITOR.pdf; http://repository.unair.ac.id/89459/; https://juri.urologi.or.id/juri/article/view/353; https://doi.org/10.32421/juri.v15i2.353
• Institution: Universitas Airlangga

Objective: To compare the PSA and TGF-β1 plasma level before and after administration of a 5α-reductase inhibitor (dutasteride) and an anti estrogen (tamoxifen) in nonobstructive patients with BPH. Material and Method: We enrolled 40 patients with a diagnosis of BPH without urinary retention. Patien...